Credex Healthcare delivers hematology billing services for hematologists, hematology-oncology practices, infusion centers, and academic medical programs that manage coagulation disorders, blood cancers, anemia, and bone marrow disease. Our hematology billing specialists manage prior authorization for specialty drugs and biologics used in hematology practice and submit a complete application with all the supporting documents to ensure the first-time submission claim passes.
Credex Healthcare’s hematology revenue cycle management handles the full billing cycle, from eligibility verification and prior authorization through claim submission, denial management, and payment reconciliation.
First-pass claim approval rate
Average hematology billing turnaround
Medicare, Medicaid & commercial networks
Bone marrow & infusion documentation review
Credex Healthcare has a special process for hematology billing that checks each claim against the treating doctor’s notes, the payer’s rules for that service, and any prior-permission requirements before submission. Specific ICD-10 rules apply to blood disease billing codes, and the hematology paperwork rules for treatments such as therapeutic phlebotomy and bone marrow biopsy are stricter than those for many other types of specialty services. Hematology billing mistakes and fixes cost money for both sides: visits for under-coded infusions result in lost income per visit, and drug administration claims without the necessary paperwork leave high-dollar drug claims open to audit.
Our hematology billing services in USA cover the following:
Claims proceed to submission with verified CPT codes, correct ICD-10 diagnosis pairings, infusion time documentation matched to drug administration codes, and prior authorization on file for specialty drugs and procedures. Our team tracks every claim through adjudication and follows up before the timely filing windows close.
We manage provider enrollment for hematologists, hematology-oncology physicians, and infusion center APPs with Medicare, Medicaid, and commercial carriers, cutting the gap between a new provider joining your practice and billing from their first patient encounter.
Denied claims are reviewed within 48 hours. Whether the rejection stemmed from a missing prior authorization for a specialty biologic, a gap in infusion time documentation, an error in bone marrow biopsy coding, or a dispute over the drug administration sequence, our team corrects it. It resubmits the documentation that the payer requires.
Our certified coders audit encounter notes and procedure records against hematology CPT codes, including 85025, 85027, 85610, and 38221, confirming that ICD-10 diagnosis codes support each service, infusion times are documented to the minute, and bone marrow procedure notes meet payer-specific documentation standards.
Specialty biologics, iron infusions, factor replacement therapy, monoclonal antibodies, and certain diagnostic procedures require prior authorization from most commercial payers. We initiate, track, and document authorizations before treatment begins, so no high-cost drug or procedure is denied after administration.
End-to-end RCM covers eligibility verification, E&M and procedure charge capture, drug administration coding, infusion center billing, payment posting, and monthly reporting, so hematology practice administrators have accurate collection data by service type and payer each billing cycle.
As a dedicated hematology billing company in the USA, Credex Healthcare tracks Medicare coverage policies for hematology services under Part B and Part D, monitors commercial payer prior authorization requirement changes for specialty hematology drugs, and maintains current documentation standards for bone marrow biopsy billing codes, coagulation testing panels, and infusion drug administration coding. Medicare coverage for hematology services depends on the specific diagnosis, the ordered service or drug, and the documentation in the encounter or procedure record. For high-cost biologics and gene therapies used in hematology, the prior authorization process alone involves clinical documentation, step-therapy requirements, and case-management review that can span several weeks.
Medicare covers hematology services under Part B for medically necessary E&M services, diagnostic laboratory testing, procedures such as bone marrow biopsy, and drug administration when the drug is on the Part B covered drug list. We manage Medicare hematology billing with correct coverage documentation, LCD compliance, and Part B drug billing under the appropriate J-codes.
Medicaid hematology coverage and prior authorization requirements differ significantly by state. Specialty biologics used to treat hemophilia, sickle cell disease, and blood cancers often require complex PA pathways within Medicaid managed care programs. Our team manages state-specific Medicaid hematology billing and PA workflows for every state where your practice operates.
Hematology practices with on-site infusion centers to bill drug administration codes alongside the drug itself, using the correct hierarchy of initial and sequential infusion codes, push codes, and concurrent infusion add-ons. We manage infusion center billing as a dedicated workflow, with time-based documentation review for every encounter.
For combined hematology-oncology practices, we coordinate provider-level billing, incident-to billing rules for APP encounters, and separation of hematology and oncology claim workflows where payer contracts require distinct billing for each specialty.
Hematology claims fail for specific, preventable reasons: infusion times not documented to support the number of units billed, bone marrow biopsy notes that do not describe the approach and specimen adequacy, prior authorizations for specialty drugs that expired before the next treatment cycle, and drug administration sequences coded incorrectly when multiple agents are given at the same visit. Credex Healthcare builds a documentation review into every claim before submission.
Every hematologist, hematology-oncology physician, and infusion center APP is verified for active enrollment with each payer, correct specialty taxonomy, and current credentialing status before claims are submitted under their provider number.
We audit laboratory orders and results against hematology CPT codes, including 85025 (CBC with differential), 85027 (CBC without differential), 85610 (prothrombin time), and coagulation and hemoglobin electrophoresis panels, confirming that ICD-10 diagnosis codes support each ordered test and that results are documented in the record.
Bone Marrow Procedure Documentation
CPT 38221 (bone marrow biopsy) and 38220 (bone marrow aspiration) each require documentation of the approach, anatomic site, patient positioning, and specimen adequacy. We review bone marrow biopsy billing claims for these elements before charge entry to prevent documentation-based denials associated with these procedures.
Infusion Time & Drug Administration Review
Drug administration codes are time-based. The initial infusion threshold, sequential infusion add-ons, concurrent infusion rules, and IV push codes each require documented start and stop times for each agent. We verify infusion time documentation against the drug administration codes billed on every infusion encounter.
Prior Authorization & Step Therapy Tracking
Specialty biologics, monoclonal antibodies, and factor replacement products require prior authorization and step-therapy documentation for many commercial payers. We track authorization status, step therapy completion records, and renewal timelines for every patient on a specialty hematology drug regimen.
Accounts Receivable Follow-Up
Hematology AR is reviewed weekly. High-dollar drug administration claims approaching timely filing are escalated immediately. Underpayments on specialty drug claims are checked against contract rates, and infusion time disputes are escalated with the documented administration records.
Hematology practices lose revenue through billing gaps that are harder to spot than standard specialty denials. Infusion visits where the documented time supports three units, but only two were billed because the coder used a conservative estimate. Bone marrow biopsy claims were denied because the procedure note did not document specimen adequacy, which most payers require. Specialty drug prior authorizations that expired mid-cycle because nobody tracked the renewal date on a patient receiving monthly infusions. Credex Healthcare’s hematology billing process catches those problems at the charge entry stage, not when the EOB arrives six weeks later.
End-to-end hematology insurance billing from charge capture and E&M code review through laboratory, procedure, and drug administration code assignment and electronic submission to Medicare, Medicaid, and commercial payers for every encounter.
Our hematology billing specialists apply the correct blood disorder billing codes and modifiers for every service type, laboratory panel, bone marrow procedure, and infusion encounter, cutting the denials from hematology documentation requirement errors.
Prior Authorization Management
Prior authorization for hematology procedures and specialty drugs is tracked per patient and per payer. Step therapy documentation and renewal timelines are monitored against each patient's treatment cycle, so no infusion or procedure is denied post-administration.
Denial management for hematology claims covers infusion time documentation corrections, bone marrow procedure note deficiencies, drug administration sequence disputes, and specialty drug prior authorization appeals. Each appeal is built around the clinical documentation and payer policy that reverses the denial.
Provider application management covers initial enrollment for hematologists and APPs, infusion center facility enrollment where applicable, and ongoing recredentialing, so your practice bills without interruption as payer agreements renew or new providers join.
Monthly reports cover collections by service type and payer, infusion drug billing performance, denial trends by CPT code, bone marrow procedure billing accuracy, hematology billing turnaround time, and AR aging, so practice owners have data to manage the business.
Years of Hematology Billing Expertise
Provider Credentialing & Enrollment Success
Claim Compliance Rate Across All Payers
Support Available for All Your Needs
Customized Hematology Revenue Cycle Solutions
MD
Obinna
“Our infusion center was losing money on hemophilia factor infusion billing because the nursing staff was not documenting start and stop times for each agent when multiple factors were given at the same visit. The billing team was using a flat rate estimate rather than time-based coding. Credex identified the documentation gap in the first audit, retrained the nursing staff on time capture, and corrected the charge-entry template. Monthly infusion center revenue went up 19% without adding a single new patient.”
MD
Eze
“We had persistent bone marrow biopsy denials from two commercial payers and kept getting told the documentation was insufficient. Nobody could tell us what was specifically missing. Credex reviewed the denied procedure notes and found that our physicians were not documenting specimen adequacy, which both payers required as a distinct line in the procedure note. One addition to the note template, and the denials stopped. We also recovered most of the backlog through appeals with the corrected documentation.”
Revenue Cycle Director
Josephine
“Managing prior authorizations for specialty biologics across a panel of 600 active hematology patients is genuinely complex. Different payers, different step-therapy requirements, and different renewal cycles. Before Credex, we had PA lapses on about 12% of monthly infusions. Their tracking system reduced this to under 2% within the first quarter. For a practice billing high-cost drugs, a 10% reduction in post-service denials is a significant dollar amount.”
MD
Kwabena
“My previous billing company was using a generic sickle cell code across all encounter types. Credex separated the coding by clinical status and applied the correct ICD-10 code based on the encounter note, and my denial rate on sickle cell infusion claims dropped from 18% to under 4%.”
CFO
David
“The billing inconsistency between sites was significant before Credex. Same procedure, same drug, different billing at each location because there was no standardized workflow. Credex audited all three sites, standardized the charge entry process, and built a monthly report that shows infusion billing performance by site. Now I can see where each location stands on drug administration coding accuracy without requesting a manual analysis.”
Practice Assessment
We audit your current hematology billing workflow, infusion center charge-capture process, AR aging by service type and payer, denial history by CPT code and reason, prior-authorization tracking gaps, and bone marrow procedure documentation accuracy. This identifies exactly where revenue is falling short.
Credentialing & Payer Enrollment
It is made sure that every hematologist and APP is currently enrolled with all payers, that they are in the right field of taxonomy, and that they have all their credentials. Infusion center building registration is checked separately if your office has an infusion room on-site.
Prior Authorization Setup
We find all your patients’ drugs, biologics, and procedures that need to be approved by the payer ahead of time. We then set up a tracking system for each patient tied to their injection plan and make sure that permission and step therapy status are confirmed before each treatment cycle starts.
Clean Claim Submission
Our hematology billing experts review interaction paperwork, ensure the correct CPT codes are used for lab tests, bone marrow treatments, and drug administration sequences, verify that evidence of injection time supports every unit billed, and send claims online to all payers.
Denial Management & Follow-Up
As a claim moves through the process, it is tracked. Within 48 hours, denials are looked over again. When there are disagreements about infusion times, incomplete bone marrow paperwork, or requests for specialty drugs' prior authorization, each one receives a specific answer based on the clinical records and insurance policy to overturn the rejection.
Reporting & Ongoing Optimization
The monthly reports cover collections by service type and payer, the accuracy of billing for intravenous drugs, rejection trends by CPT code, the performance of billing for bone marrow procedures, the time it takes to process hematology bills, and the age of accounts receivable. Documentation problems that keep happening are fixed at the level of the clinical process, not just in bills.
Hematology billing includes both E&M coding and laboratory panel billing. It also includes time-based drip drug delivery coding, complicated process paperwork for bone marrow biopsy, and managing prior clearance for some of the most expensive drugs in medicine. Some of that is done right by a general billing company, but others are missed in ways that aren’t clear until the AR starts to rise. Credex Healthcare specializes in hematology medical billing because this field needs billing experts who know how to provide the full range of services and the specific paperwork that each part needs.
Our team works on hematology claims. We understand the time-based infusion coding hierarchy, documentation standards, payers’ requirements for bone marrow biopsy, step-therapy requirements for specialty biologics, and the most common sources of denials for blood disorder billing codes. Hematology billing is not adapted from a general oncology or internal medicine workflow here.
Your practice has one hematology billing expert who is only responsible for that area of billing. This person understands your patients, your specialty drug panel, your payer contracts, and the patterns of claims that keep getting denied. Problems are handled by someone who already knows everything about the bills and clinical situations.
Monthly reports show the real financial state of the business. They show payments by service type and payer, injection drug billing performance by drug and site, rejection trends by CPT code, bone marrow treatment accuracy, and hematology billing response time.
Full HIPAA compliance measures protect all patient records, lab data, injection treatment logs, and procedure notes that are handled during the payment process. Every system that handles claims for your business follows strict security rules and allows only certain people to access it.
Hematology practices lose revenue through billing gaps that compound month after month. Infusion visits in which time-based coding was not used consistently because start and end times were never recorded. Bone marrow test claims were denied because they lacked the required wording about material sufficiency. Prior authorizations for specialty drugs expired in the middle of a cycle for patients who get monthly injections. These are issues with the way work gets done, not just one-time billing mistakes. All of them are found in the first few weeks of an audit.
Credex Healthcare begins with a free review of your current hematology billing. This includes a look at your arrangement by service type and payer, your rejection history by CPT code and reason, the accuracy of your injection paperwork, the compliance of your bone marrow treatment notes, and any gaps in your prior permission. You do not have to make a promise to get that rating. We figure out how much money can be recovered and what changes need to be made to the process so that the same losses don’t happen again next quarter.
Hematology billing is the process of being paid for medical care for conditions that affect the blood, such as anemia, blood cancers, and bone marrow disorders. Hematology billing is especially hard because drug administration billing is time-based and requires documenting start and stop times for every administered agent. Also, most commercial payers require step-therapy documentation for specialty biologics before they pay for treatment.
Medicare processes clean electronic hematology claims in 14 to 30 days when documentation supports all submitted codes. Commercial payers usually pay within 30 days as long as there is proof of prior authorization and a complete record of the injection time. Timelines for Medicaid vary by state but are usually between 30 and 60 days. All three of these issues are taken care of by Credex Healthcare’s review of the paperwork and tracking of prior authorizations before claims are furnished. This keeps most hematology claims within the standard billing timeframe for this field.
The billing industry is rapidly evolving. By the year 2025, the system and tools used
Billing companies ensure compliance with HIPAA and other regulations by being legitimate and reliable. Every
At Credex Healthcare, we know how frustrating it is when claims are denied. That is
Fill the form and someone from our team will get back to you. Or you can also call us on (833) 477-1261.